
Joel S. Mindel
- PROFESSOR Ophthalmology
- ASSOCIATE PROFESSOR Pharmacology and Systems Therapeutics
Print Profile
Specialty
Certifications
Ophthalmology
Clinical Focus
Education
MD, University of Maryland
Internship, Ophthalmology
University of Michigan HospitalsResidency, Ophthalmology
University of Michigan HospitalsFellowship, Neuro-Ophthalmology
Columbia-Presbyterian Medical CenterFellowship, Occular Pharmacology
Mount Sinai Hospital
Biography
- Dr. Joel Mindel is a Professor of Neuro-Ophthalmology and Associate Professor of Pharmacology. He is the Director of Neuro-Ophthalmology at the Mount Sinai School of Medicine and has served as the Chief of the Ophthalmology Section at the Bronx Veterans Administration Hospital since 1973.
Dr. Mindel received his B.A. at Swarthmore College and his M.D. from the University of Maryland. He did his internship and residency at the University of Michigan, where he returned to achieve his M.S. in Ophthalmology after completing a fellowship in Neuro-Ophthalmology at Columbia-Presbyterian Hospital. Dr. Mindel completed a second fellowship in Ocular-Pharmacology at the Mount Sinai School of Medicine, where he then received his Ph.D. in Pharmacology. He is a Diplomate of the American Board of Ophthalmology.
A member of both the American Academy of Ophthalmology and the Americal Ophthalmological Society, Dr. Mindel serves as a consultant to the FDA Dermatologic and Ophthalmic Drugs Advisory Committee and as a delegate from both Mount Sinai and the American Academy of Ophthalmology to the US Pharmacopeial Convention. Dr. Mindel serves on the Editorial Board and Editorial Advisory Board for Ophthalmology, and has for the past 20 years been co-editor of the Ocular Pharmacology Section of Duane's Biomedical Foundations of Ophthalmology. Now in his 15th year, he continues as Co-editor of Therapeutic Reviews for Survey of Ophthalmology.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Mindel did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
17 East 102nd Street
8th Floor-West
New York, NY 10029
Fax: 212-824-2325


- Monday 8:00am - 3:00pm
- Thursday 8:00am - 3:00pm
- Spanish
- 1199 National Benefit Fund
- Devon Health Services
- Medicaid
- Medicare
- Medicare Assignment
- PHS/Healthnet/Guardian
- United Healthcare
- Master Card
- Visa
- American Express
- Personal Check
- Cash
5 East 98th Street
7th Floor
New York, NY 10029
Fax: 212-427-4410


- Monday 8:00am - 3:00pm
- Wednesday 8:00am - 3:00pm

